Z-2029-2026 Class II Ongoing
FDA device recall Z-2029-2026 was initiated by Medline Industries, LP on Mar 19, 2026 and is designated Class II. Reason for recall: During an internal review, Medline identified higher-than-expected endotoxin levels on a representative Medline neuro sponge product, indicating that in-market product may be out-of-specification for… The recall status is ongoing. Affected quantity: 340 kits.
Recall details
- Product Type
- Devices
- Report Date
- May 6, 2026
- Initiation Date
- Mar 19, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 340 kits
Product description
Medline medical procedure kits, containing Medline Neuro Sponges, labeled as follows: CERVICAL PACK, Medline Kit Number/SKU DYNJ37902F
Reason for recall
During an internal review, Medline identified higher-than-expected endotoxin levels on a representative Medline neuro sponge product, indicating that in-market product may be out-of-specification for endotoxin.
Distribution pattern
Worldwide distribution.
Code information
UDI/DI each 10889942930883, UDI/DI case 40889942930884, Lot Numbers: 21GBA316, 21FBA411, 21DBI004, 21BBS142.
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2029-2026
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026